<?xml version="1.0" encoding="UTF-8"?>
<document id="DDI-DrugBank.d11">
    <sentence id="DDI-DrugBank.d11.s0" text="Drug-Drug Interactions Albuterol - STRATTERA should be administered with caution to patients being treated with systemically-administered (oral or intravenous) albuterol (or other beta2 agonists) because the action of albuterol on the cardiovascular system can be potentiated resulting in increases in heart rate and blood pressure.">
        <entity id="DDI-DrugBank.d11.s0.e0" charOffset="23-31"
            type="drug" text="Albuterol"/>
        <entity id="DDI-DrugBank.d11.s0.e1" charOffset="35-43"
            type="brand" text="STRATTERA"/>
        <entity id="DDI-DrugBank.d11.s0.e2" charOffset="160-168"
            type="drug" text="albuterol"/>
        <entity id="DDI-DrugBank.d11.s0.e3" charOffset="180-193"
            type="group" text="beta2 agonists"/>
        <entity id="DDI-DrugBank.d11.s0.e4" charOffset="218-226"
            type="drug" text="albuterol"/>
        <ddi id="DDI-DrugBank.d11.s0.d0" e1="DDI-DrugBank.d11.s0.e1"
            e2="DDI-DrugBank.d11.s0.e2" type="advise"/>
    </sentence>
    <sentence id="DDI-DrugBank.d11.s1" text="CYP2D6 inhibitors - Atomoxetine is primarily metabolized by the CYP2D6 pathway to 4-hydroxyatomoxetine.">
        <entity id="DDI-DrugBank.d11.s1.e0" charOffset="20-30"
            type="drug" text="Atomoxetine"/>
        <entity id="DDI-DrugBank.d11.s1.e1" charOffset="82-101"
            type="drug_n" text="4-hydroxyatomoxetine"/>
    </sentence>
    <sentence id="DDI-DrugBank.d11.s2" text="In EMs, selective inhibitors of CYP2D6 increase atomoxetine steady-state plasma concentrations to exposures similar to those observed in PMs.">
        <entity id="DDI-DrugBank.d11.s2.e0" charOffset="48-58"
            type="drug" text="atomoxetine"/>
    </sentence>
    <sentence id="DDI-DrugBank.d11.s3" text="Dosage adjustment of STRATTERA may be necessary when coadministered with CYP2D6 inhibitors, e.g., paroxetine, fluoxetine, and quinidine.">
        <entity id="DDI-DrugBank.d11.s3.e0" charOffset="21-29"
            type="brand" text="STRATTERA"/>
        <entity id="DDI-DrugBank.d11.s3.e1" charOffset="98-107"
            type="drug" text="paroxetine"/>
        <entity id="DDI-DrugBank.d11.s3.e2" charOffset="110-119"
            type="drug" text="fluoxetine"/>
        <entity id="DDI-DrugBank.d11.s3.e3" charOffset="126-134"
            type="drug" text="quinidine"/>
        <ddi id="DDI-DrugBank.d11.s3.d0" e1="DDI-DrugBank.d11.s3.e0"
            e2="DDI-DrugBank.d11.s3.e1" type="advise"/>
        <ddi id="DDI-DrugBank.d11.s3.d1" e1="DDI-DrugBank.d11.s3.e0"
            e2="DDI-DrugBank.d11.s3.e2" type="advise"/>
        <ddi id="DDI-DrugBank.d11.s3.d2" e1="DDI-DrugBank.d11.s3.e0"
            e2="DDI-DrugBank.d11.s3.e3" type="advise"/>
    </sentence>
    <sentence id="DDI-DrugBank.d11.s4" text="In EM individuals treated with paroxetine or fluoxetine, the AUC of atomoxetine is approximately 6- to 8-fold and Css,max is about 3- to 4-fold greater than atomoxetine alone.">
        <entity id="DDI-DrugBank.d11.s4.e0" charOffset="31-40"
            type="drug" text="paroxetine"/>
        <entity id="DDI-DrugBank.d11.s4.e1" charOffset="45-54"
            type="drug" text="fluoxetine"/>
        <entity id="DDI-DrugBank.d11.s4.e2" charOffset="68-78"
            type="drug" text="atomoxetine"/>
        <entity id="DDI-DrugBank.d11.s4.e3" charOffset="157-167"
            type="drug" text="atomoxetine"/>
        <ddi id="DDI-DrugBank.d11.s4.d0" e1="DDI-DrugBank.d11.s4.e0"
            e2="DDI-DrugBank.d11.s4.e2" type="mechanism"/>
        <ddi id="DDI-DrugBank.d11.s4.d1" e1="DDI-DrugBank.d11.s4.e1"
            e2="DDI-DrugBank.d11.s4.e2" type="mechanism"/>
    </sentence>
    <sentence id="DDI-DrugBank.d11.s5" text="In vitro studies suggest that coadministration of cytochrome P450 inhibitors to PMs will not increase the plasma concentrations of atomoxetine.">
        <entity id="DDI-DrugBank.d11.s5.e0" charOffset="131-141"
            type="drug" text="atomoxetine"/>
    </sentence>
    <sentence id="DDI-DrugBank.d11.s6" text="Pressor agents - Because of possible effects on blood pressure, STRATTERA should be used cautiously with pressor agents.">
        <entity id="DDI-DrugBank.d11.s6.e0" charOffset="64-72"
            type="brand" text="STRATTERA"/>
    </sentence>
</document>
